← Back to Search

Behavioural Intervention

MY-RIDE Program for HIV Prevention

N/A
Waitlist Available
Led By Diane M Santa Maria, DrPH, MSN, RN, PHNA-BC, FSAHM,
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3, 6, and 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a program to reduce substance use and encourage HIV prevention strategies among teens. It will measure the effects on stress, substance use urges, and use of services.

Who is the study for?
This trial is for English-speaking youth experiencing homelessness in the metro area, who have used substances and been sexually active recently or plan to be. They should not be planning to move during the study year and must be able to read well enough (RELM-SF score ≥ 4).
What is being tested?
The MY-RIDE program aims to reduce substance use and increase HIV prevention strategies among homeless youth. It will be compared with an attention-control group, focusing on willingness to take PrEP, stress levels, urges for substance use, and mental health service usage.
What are the potential side effects?
Since this intervention involves behavioral support rather than medication, typical medical side effects are not expected. However, participants may experience emotional discomfort when discussing personal issues related to substance use or sexual behavior.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3, 6, and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change in PrEP uptake as assessed by the self reported tool
Change in sexually transmitted infections (STIs)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MY-RIDE groupExperimental Treatment1 Intervention
Group II: Attention-control groupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
946 Previous Clinical Trials
343,839 Total Patients Enrolled
National Institute of Nursing Research (NINR)NIH
600 Previous Clinical Trials
10,377,129 Total Patients Enrolled
Diane M Santa Maria, DrPH, MSN, RN, PHNA-BC, FSAHM,Principal InvestigatorThe University of Texas Health Science Center, Houston
~270 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top